Drug
ERB 041 clinical trials
Also written ERB-041.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2004
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
6 studies that test it; most in 2006 (4)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Studies
Open first, then newest update. How each study uses ERB 041 is read from its arms, and is right about nine times in ten.
Testing it · 6
- Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial CystitisWithdrawnNot applicableWyeth is now a wholly owned subsidiary of PfizerNCT00275379Written as ERB-041
- Study Evaluating ERB-041 in Endometriosis in Reproductive-Age WomenCompletedPhase 2Wyeth is now a wholly owned subsidiary of PfizerNCT00110487Written as ERB-041
- Study Evaluating ERB-041 in Active Crohn's DiseaseCompletedPhase 1Wyeth is now a wholly owned subsidiary of PfizerNCT00245947Written as ERB-041
- Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese SubjectsCompletedPhase 1Wyeth is now a wholly owned subsidiary of PfizerNCT00434187Written as ERB-041
- Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged WomenCompletedPhase 2Wyeth is now a wholly owned subsidiary of PfizerNCT00318500Written as ERB-041
- Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy SubjectsCompletedPhase 1Wyeth is now a wholly owned subsidiary of PfizerNCT00316459Written as ERB-041